» Authors » Raul Rodriguez

Raul Rodriguez

Explore the profile of Raul Rodriguez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 83
Citations 529
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez R, Aviles N
Clin Pract Cases Emerg Med . 2025 Feb; 9(1):98-101. PMID: 39903639
Introduction: This case highlights the advances that have been made when skilled sonographers using point-of-care ultrasound (POCUS) are able to evaluate for more than free fluid on the focused assessment...
2.
Shanok N, Bright E, Muzac S, Baumeister C, Lahr T, Cabeza E, et al.
Appl Neuropsychol Adult . 2024 Oct; :1-13. PMID: 39395193
Background: Perceived purpose in life (PIL) is linked with many vital health outcomes, including Major Depressive Disorder (MDD). Methods: In this study, biomarkers associated with depression and PIL were investigated...
3.
Bohada-Lizarazo D, Bravo-Sanabria K, Cardenas-Malpica P, Rodriguez R
Trop Med Infect Dis . 2024 Sep; 9(9). PMID: 39330886
Tuberculosis (TB) is an important infectious disease in relation to global public health and is caused species of the complex (MTBC). In this study, we used whole-genome sequencing (WGS) and...
4.
Shanok N, Muzac S, Derbin B, Cabeza E, Rodriguez R
Neurocase . 2024 Apr; 29(3):81-86. PMID: 38678309
Numerous treatment options are being studied for Alzheimer's disease (AD) given the rising prevalence of this condition worldwide. Transcranial Magnetic Stimulation (TMS) is a promising option for regulating specific neurological...
5.
Rabago D, Fernandez E, Celaya S, Fuente I, Fernandez A, Quindos J, et al.
Sensors (Basel) . 2024 Mar; 24(6). PMID: 38544099
A comparison of low-cost radon monitors was conducted at the Laboratory of Natural Radiation (LNR). The monitors we evaluated were EcoQube, RadonEye, RadonEye Plus2, Spirit, ViewPlus, ViewRadon and WavePlus. An...
6.
Shanok N, Muzac S, Brown L, Barrera M, Rodriguez R
Psychopharmacology (Berl) . 2024 Mar; 241(7):1427-1433. PMID: 38472415
Objective: Major Depressive Disorder (MDD) is a pervasive psychiatric condition effecting approximately 21 million adults in the U.S. (8.4%). An estimated 30-60% of patients are resistant to traditional treatment approaches...
7.
Llados G, Massanella M, Coll-Fernandez R, Rodriguez R, Hernandez E, Lucente G, et al.
Clin Microbiol Infect . 2023 Nov; 30(4):515-521. PMID: 37984511
Objectives: The post-COVID-19 condition (PCC) is a disabling syndrome affecting at least 5%-10% of subjects who survive COVID-19. SARS-CoV-2 mediated vagus nerve dysfunction could explain some PCC symptoms, such as...
8.
Gutierrez-Castaneda L, Acosta C, Bustos M, Garcia D, Bohada D, Rodriguez R, et al.
Trop Med Infect Dis . 2023 Oct; 8(10). PMID: 37888601
Background: Single nucleotide variants in toll-like receptor genes play a crucial role in leprosy susceptibility or resistance. Methods: With an epidemiology case-control study, associations between SNVs rs5743618 in TLR1, rs5743708...
9.
Shanok N, Rodriguez S, Muzac S, Huertas Del Pino C, Brown L, Rodriguez R
J Affect Disord . 2023 May; 337:104-111. PMID: 37230266
Objective: Major depressive disorder (MDD) is one of the most prevalent and debilitating health conditions worldwide; unfortunately, many patients do not respond to traditional antidepressant medication or talk therapy approaches....
10.
Patino L, Ballesteros N, Munoz M, Ramirez A, Luna N, Castaneda S, et al.
J Med Virol . 2023 May; 95(4):e28766. PMID: 37185861
No abstract available.